GI Innovation (KQ:358570) announced that it signed a Memorandum of Understanding (MOU) with LaNova Medicines (LaNova) for the ...
BPGbio shares results of Project Survival clinical trial identifying novel pancreatic cancer patient subtypes at ASCO GI 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback